QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cl-king-initiates-coverage-on-haemonetics-with-buy-rating-announces-price-target-of-116

CL King analyst Kristen Stewart initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of...

 b-of-a-securities-initiates-coverage-on-haemonetics-with-neutral-rating-announces-price-target-of-85

B of A Securities analyst Craig Bijou initiates coverage on Haemonetics (NYSE:HAE) with a Neutral rating and announces Price...

 btig-initiates-coverage-on-haemonetics-with-buy-rating-announces-price-target-of-112

BTIG analyst Marie Thibault initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of $112.

 citigroup-maintains-neutral-on-haemonetics-lowers-price-target-to-85

Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Neutral and lowers the price target from $94 to $85.

 jmp-securities-reiterates-market-outperform-on-haemonetics-maintains-125-price-target

JMP Securities analyst David Turkaly reiterates Haemonetics (NYSE:HAE) with a Market Outperform and maintains $125 price tar...

 barrington-research-maintains-outperform-on-haemonetics-raises-price-target-to-108

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target f...

 haemonetics-q1-adj-102-beats-101-estimate-sales-33617m-beat-33538m-estimate

Haemonetics (NYSE:HAE) reported quarterly earnings of $1.02 per share which beat the analyst consensus estimate of $1.00 by 2 p...

 haemonetics-announced-ce-mark-certification-and-the-first-commercial-european-procedures-for-savvywire-pre-shaped-pressure-guidewire

The SavvyWire guidewire is the world's first and only sensor-guided 3-in-1 solution for Transcatheter Aortic Valve Implanta...

 haemonetics-strategic-moves-poised-to-boost-margins-and-earnings-says-analyst

Analyst upgrades Haemonetics to Buy, believes company can reach high-20% operating margin goal by FY26 through product mix anal...

 needham-upgrades-haemonetics-to-buy-announces-112-price-target

Needham analyst Mike Matson upgrades Haemonetics (NYSE:HAE) from Hold to Buy and announces $112 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION